Literature DB >> 2538900

Brain enzyme changes as markers of brain damage in rat cardiac arrest model. Effects of corticosteroid therapy.

L Katz1, P Vaagenes, P Safar, W Diven.   

Abstract

Apneic asphyxia to cardiac arrest (CA) in rats of 10 min was reversed by cardiopulmonary resuscitation (CPR), and after controlled ventilation and controlled normotension for 20 min, was followed by decapitation and brain freezing, and determination of brain concentrations of cytosolic and lysosomal enzymes. Normal values came from a control group of 10 rats without CA. In 20 rats with CA brain cytosolic enzymes CK, LD, and ASAT decreased post-arrest, while lysosomal enzyme changes were variable (Table I). Brain lactate increased 8-10-fold post-CA. To test the model, effect of methylprednisolone (MP) was studied. The 20 rats with CA were divided into 4 groups: Group I, received placebo pre-CA; Group II, MP 30 mg/kg i.v. pre-CA; Group III, placebo post-CA; and Group IV, MP post-CA. The post-CA MP Group IV was the only one without norepinephrine requirement and with return of EEG activity at 20 min. Brain CK, LD, and ASAT losses post-CA were not different between groups; and showed no differences between MP groups II and IV vs. placebo Groups I and III. When comparing both pre-CA Groups (I and II) with both post-CA Groups (III and IV), post-CA CK and ASAT levels were the same, but LD was higher in the post-CA treatment group. The lysosomal enzymes acid phosphatase, mannosidase, beta-glucuronidase and hexosaminidase showed variable concentration changes post-CA in the four groups, with a trend toward a lesser increase of some after MP or after post-treatment. Brain enzyme changes in our asphyxial CA rat model can serve as markers of brain damage. MP post-CA might enhance cardiovascular and EEG recovery, but does not seem to influence brain enzyme levels at 20 min post-CA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538900     DOI: 10.1016/0300-9572(89)90078-6

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  6 in total

1.  Therapeutic hypothermia promotes cerebral blood flow recovery and brain homeostasis after resuscitation from cardiac arrest in a rat model.

Authors:  Qihong Wang; Peng Miao; Hiren R Modi; Sahithi Garikapati; Raymond C Koehler; Nitish V Thakor
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-09       Impact factor: 6.200

Review 2.  Brain resuscitation in the drowning victim.

Authors:  Alexis A Topjian; Robert A Berg; Joost J L M Bierens; Christine M Branche; Robert S Clark; Hans Friberg; Cornelia W E Hoedemaekers; Michael Holzer; Laurence M Katz; Johannes T A Knape; Patrick M Kochanek; Vinay Nadkarni; Johannes G van der Hoeven; David S Warner
Journal:  Neurocrit Care       Date:  2012-12       Impact factor: 3.210

Review 3.  Pharmacological Approach for Neuroprotection After Cardiac Arrest-A Narrative Review of Current Therapies and Future Neuroprotective Cocktail.

Authors:  Rishabh C Choudhary; Muhammad Shoaib; Samantha Sohnen; Daniel M Rolston; Daniel Jafari; Santiago J Miyara; Kei Hayashida; Ernesto P Molmenti; Junhwan Kim; Lance B Becker
Journal:  Front Med (Lausanne)       Date:  2021-05-18

Review 4.  Glucocorticoids as an emerging pharmacologic agent for cardiopulmonary resuscitation.

Authors:  Giolanda Varvarousi; Antonia Stefaniotou; Dimitrios Varvaroussis; Theodoros Xanthos
Journal:  Cardiovasc Drugs Ther       Date:  2014-10       Impact factor: 3.727

5.  Steroid use after cardiac arrest is associated with favourable outcomes: a systematic review and meta-analysis.

Authors:  Bo Liu; Qiang Zhang; Chunsheng Li
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

6.  Efficacy of combination triple therapy with vasopressin, steroid, and epinephrine in cardiac arrest: a systematic review and meta-analysis of randomized-controlled trials.

Authors:  Fatemeh Saghafi; Negar Bagheri; Amin Salehi-Abargouei; Adeleh Sahebnasagh
Journal:  J Intensive Care       Date:  2022-02-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.